UBT-38006

N/A

Report date: 2026/05/11 20:01:57

Base Information

Drug NameUBT-38006
Drug Alias NameUBT38006超长效胰岛素UBT38006UBT-38006
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesUnited Laboratories International Holdings Limited -The-
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesUnited Laboratories International Holdings Limited -The-Lianbang Biotechnology (Zhuhai Hengqin) Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A